Redirect Notice
The previous page is sending you to
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19
.
If you do not want to visit that page, you can
return to the previous page
.